CytRx Corp. buy tbackenh
Start price
19.05.17
/
50%
€2.81
Target price
02.06.17
€6.49
Performance (%)
53.03%
End price
02.06.17
€4.30
Summary
This prediction ended on 02.06.17 with a price of €4.30. The BUY prediction by tbackenh for CytRx Corp. saw massive gains of 53.03%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% | 49.858% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% | 100.330% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% | 65.355% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% | 68.657% |
Comments by tbackenh for this prediction
In the thread CytRx Corp. diskutieren
CytRx Corp.
Interessant wird die Veröffentlichung der Phase-3-Studie in Q3. Ein positives Ergebnis könnte Rüclenwind bedeuten.
(Stop Loss Kurs erreicht)